摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-5-氟-1,3-二甲苯 | 14994-16-2

中文名称
2-氯-5-氟-1,3-二甲苯
中文别名
2,6-二甲基-4-氟氯苯
英文名称
1-chloro-4-fluoro-2,6-dimethylbenzene
英文别名
2-chloro-5-fluoro-1,3-dimethylbenzene;4-chloro-1-fluoro-3,5-dimethylbenzene;5-Fluor-2-chlor-1,3-dimethyl-benzol;4-Chlor-3,5-dimethyl-fluorbenzol;Chlor-fluor-xylol
2-氯-5-氟-1,3-二甲苯化学式
CAS
14994-16-2
化学式
C8H8ClF
mdl
——
分子量
158.603
InChiKey
MVJOCJGXPDHQEN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    63-64 °C(Press: 10 Torr)
  • 密度:
    1.148±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2903999090

SDS

SDS:e97cefb23ed1ed1f0a83806a745de3ca
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    HETEROARYL DERIVATIVES
    摘要:
    本发明涉及一种由公式[1]表示的化合物或其药学上可接受的盐: 在公式[1]中,X和Y中的一个是CH,另一个是氧或硫;R是氢等;Z是氢等;Ar是苯等;n为1或2,m为1或2,不包括n为2且m为2的化合物。还提供了一种药物组合物,其包括公式[1]的化合物或其药学上可接受的盐作为活性成分。该组合物可作为预防或治疗抑郁症、惊恐障碍、焦虑症、强迫症、慢性疼痛、纤维肌痛、肥胖症、压力性尿失禁和过度活动膀胱的药物。
    公开号:
    US20100048537A1
  • 作为产物:
    参考文献:
    名称:
    Substituent Effects. IX.1 H and 19F Nuclear Magnetic Resonance Spectra of 4-Substituted 3,5-Dimethylfluorobenzenes2
    摘要:
    DOI:
    10.1021/ja00978a039
点击查看最新优质反应信息

文献信息

  • Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith
    申请人:Bayer Aktiengesellschaft
    公开号:US06288081B1
    公开(公告)日:2001-09-11
    The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl radical, and of their salts for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders.
    该发明涉及使用在位置7被1-基甲基-2-氧-7-氮代双环[3.3.0]辛-7-基取代的喹诺酮酮羧酸生物,以及它们的盐用于治疗幽门螺杆菌感染和相关的胃十二指肠疾病。
  • Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic
    申请人:Bayer Aktiengesellschaft
    公开号:US06133260A1
    公开(公告)日:2000-10-17
    The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.
    该发明涉及使用在7位被2-氧杂-5,8-二氮杂双环[4.3.0]-壬-8-基基团取代的喹诺酮酮羧酸生物,以及它们的药用合物和/或盐来治疗幽门螺杆菌感染及相关的胃十二指肠疾病。
  • 3-cyano-2,4,5-trifluoro-benzoyl fluoride and intermediate products for the production thereof
    申请人:Bayer Aktiengesellschaft
    公开号:US06229040B1
    公开(公告)日:2001-05-08
    The present invention relates to 3-cyano-2,4,5-trifluorobenzoyl fluoride and to intermediates for its preparation and to the process for the preparation of 3-cyano-2,4,5-trifluoro-benzoyl fluoride, which starts from 5 fluoro-1,3-xylene (VIII); which is bichlorinated in the ring in the presence of a catalyst under ionic conditions to give 2,4-dichloro-5-fluoro-1,3 dimethylbenzene (VII). The latter is chlorinated in the side chains under free-radical conditions to give 2,4-dichloro-5-fluoro-3-dichloromethyl-1 trichloromethylbenzene (VI). The latter is hydrolyzed via 2,4-dichloro-5-fluoro-3-dichloromethylbenzoic acid (V), which can be isolated if necessary, to give 2,4-dichloro-5-fluoro-3-formyl-benzoic acid (IV), the aldehyde group of which is reacted to give 2,4-dichloro-5-fluoro-3-N-hydroxyiminomethyl-benzoic acid (III), from which, with simultaneous conversion of the carboxyl group into the chlorocarbonyl group, water is eliminated using an acid chloride to give the nitrile 2,4-dichloro-3-cyano-5 fluoro-benzoyl chloride (II). Finally the nitrile is subjected to fluorine/chlorine exchange.
    本发明涉及3-基-2,4,5-三苯甲酰氟及其制备中间体以及制备3-基-2,4,5-三苯甲酰氟的过程,该过程始于5--1,3-二甲基苯(VIII),在离子条件下催化环中二化,得到2,4-二-5--1,3-二甲基苯(VII)。后者在自由基条件下侧链化,得到2,4-二-5--3-二甲基-1-三甲基苯(VI)。后者通过2,4-二-5--3-二氯甲基苯甲酸(V)解,必要时可以分离出,得到2,4-二氯-5-氟-3-甲酰基苯甲酸(IV),其醛基反应生成2,4-二-5--3-N-羟基亚甲基苯甲酸(III),从中通过同时将羧基转化为羰基,使用酸化物消除,得到腈2,4-二-3-基-5-苯甲酰氯(II)。最后,腈经过/交换。
  • Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders
    申请人:——
    公开号:US20010036941A1
    公开(公告)日:2001-11-01
    The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aninomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl radical, and of their salts for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders.
    本发明涉及使用在第7位被1-甲基-2-氧杂-7-氮杂双环[3.3.0]辛-7-基基团取代的喹诺酮酮羧酸生物及其盐,用于治疗幽门螺杆菌感染和相关的胃十二指肠疾病。
  • 3-Cyano-2,4,5-trifluorobenoxyl fluoride and intermediate products for the production thereof
    申请人:——
    公开号:US20040167350A1
    公开(公告)日:2004-08-26
    The present invention relates to 3-cyano-2,4,5-trifluoro-benzoyl fluoride and to intermediates for its preparation and to the process for the preparation of 3-cyano-2,4,5-trifluoro-benzoyl fluoride, which starts from 5-fluoro-1,3-xylene (VIII); which is bichlorinated in the ring in the presence of a catalyst under ionic conditions to give 2,4-dichloro-5-fluoro-1,3-dimethylbenzene (VII). The latter is chlorinated in the side chains under free-radical conditions to give 2,4-dichloro-5-fluoro-3-dichloromethyl-1-trichloromethylbenzene (VT). The latter is hydrolysed via 2,4-dichloro-5-fluoro-3-dichloromethylbenzoic acid (V), which can be isolated if necessary, to give 2,4-dichloro-5-fluoro-3-formyl-benzoic acid (IV), the aldehyde group of which is reacted to give 2,4-dichloro-5-fluoro-3-N-hydroxyiminomethyl-benzoic acid (III), from which, with simultaneous conversion of the carboxyl group into the chlorocarbonyl group, water is eliminated using an acid chloride to give the nitrile 2,4-dichloro-3-cyano-5-fluoro-benzoyl chloride (II). Finally, the nitrile is subjected to fluorine/chlorine exchange.
    本发明涉及3-基-2,4,5-三苯甲酰氟和其制备的中间体,以及制备3-基-2,4,5-三苯甲酰氟的方法。该方法从5--1,3-二甲基苯(VIII)开始,该化合物在离子条件下存在催化剂的情况下在环上进行二化反应,得到2,4-二-5--1,3-二甲基苯(VII)。然后,在自由基条件下,对其进行侧链化反应,得到2,4-二-5--3-二甲基-1-三甲基苯(VT)。然后,通过解2,4-二-5--3-二氯甲基苯甲酸(V,必要时可分离)得到2,4-二氯-5-氟-3-甲酰基苯甲酸(IV),其醛基反应得到2,4-二-5--3-N-羟基亚甲基苯甲酸(III),通过同时将羧基转化为甲酰基,使用酸化物消除,得到腈2,4-二-3-基-5-苯甲酰氯(II)。最后,对腈进行/交换。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫